Mesolella Massimo, Allosso Salvatore, Coronella Valentina, Massimilla Eva Aurora, Mansi Nicola, Motta Giovanni, Salerno Grazia, Motta Gaetano
Unit of Otorhinolaryngology, Department of Neuroscience, Reproductive Sciences and Dentistry, University Federico II of Naples, 80138 Napoli, Italy.
Unit of Otorhinolaryngology, University Luigi Vanvitelli, 80138 Napoli, Italy.
J Pers Med. 2023 May 8;13(5):806. doi: 10.3390/jpm13050806.
The objective of our study was to compare our experience of intracapsular tonsillotomy performed with the help of a microdebrider usually used for adenoidectomy with results obtained from extracapsular surgery through dissection and from adenoidectomy in cases of people affected with OSAS, linked to adeno-tonsil hypertrophy, observed and treated in the last 5 years.
3127 children with adenotonsillar hyperplasia and OSAS-related clinical symptoms (aged between 3 and 12 years) underwent tonsillectomy and/or adenoidectomy. A total of 1069 patients (Group A) underwent intracapsular tonsillotomy, while 2058 patients (Group B) underwent extracapsular tonsillectomy, from January 2014 to June 2018. The parameters considered in order to evaluate the effectiveness of the two different surgery techniques taken into consideration were as follows: the presence of possible postoperative complications, represented mainly by pain and perioperative bleeding; the level of postoperative respiratory obstruction compared with the original obstruction through night pulse oximetry, performed 6 months before and after the surgery; tonsillar hypertrophy relapse in Group A and/or the presence of residues in Group B with clinical evaluation performed 1 month, 6 months, and 1 year after the surgery; and postoperative life quality, evaluated through submitting to parents the same survey proposed before the surgery 1 month, 6 months, and 1 year after the surgery.
Regardless of the technique used (extracapsular tonsillectomy or intracapsular tonsillotomy), there was a clear improvement in both the obstructive respiratory symptomatology and quality of life in both patient groups, as highlighted by the pulse oximetry and the OSA-18 survey submitted later.
Intracapsular tonsillotomy surgery has improved in terms of a reduction in postoperative bleeding cases and pain reduction, with an earlier return to patients' usual lifestyle. Lastly, using a microdebrider with the intracapsular technique seems to be particularly effective in removing most of the tonsillar lymphatic tissue, leaving only a thin border of pericapsular lymphoid tissue and preventing lymphoid tissue regrowth during one year of follow-up.
我们研究的目的是比较在微切割器辅助下进行的囊内扁桃体切除术(该微切割器通常用于腺样体切除术)的经验,与过去5年中观察和治疗的因腺样体 - 扁桃体肥大而患有阻塞性睡眠呼吸暂停综合征(OSAS)的患者通过包膜外手术切除扁桃体以及腺样体切除术的结果。
3127例患有腺扁桃体增生和OSAS相关临床症状(年龄在3至12岁之间)的儿童接受了扁桃体切除术和/或腺样体切除术。从2014年1月至2018年6月,共有1069例患者(A组)接受了囊内扁桃体切除术,而2058例患者(B组)接受了包膜外扁桃体切除术。为评估所考虑的两种不同手术技术的有效性而考虑的参数如下:可能的术后并发症的存在,主要表现为疼痛和围手术期出血;通过手术前后6个月进行的夜间脉搏血氧饱和度测定,比较术后呼吸阻塞水平与原始阻塞情况;A组扁桃体肥大复发和/或B组术后1个月、6个月和1年进行临床评估时的残留情况;以及术后生活质量,通过在术后1个月、6个月和1年向家长提交与手术前相同的调查问卷进行评估。
无论采用何种技术(包膜外扁桃体切除术或囊内扁桃体切除术),两个患者组的阻塞性呼吸症状和生活质量均有明显改善,这一点通过脉搏血氧饱和度测定和后来提交的OSA - 18调查问卷得到了突出体现。
囊内扁桃体切除术在减少术后出血病例和减轻疼痛方面有所改善,患者能更早恢复正常生活方式。最后,在囊内技术中使用微切割器似乎在切除大部分扁桃体淋巴组织方面特别有效,仅留下一层薄薄的包膜周围淋巴组织边界,并在一年的随访期间防止淋巴组织再生。